Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Thyromax Single Daily-Dose Response in Hypothyroidism
NCT01800617Phase 2Completed
- Start
- Mar 2013
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of liothyronine in hypothyroidism. Started Mar 2013; status: completed.
02
Drugs
liothyronine
03
Conditions
hypothyroidism
Beyond the preview
Go deeper on NCT01800617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01800617.